NCT02150031

Brief Summary

The first time the American Heart Association (AHA) suggested that disinfection of the gingival sulcus be performed as a complement to antibiotic prophylaxis in patients considered to be at risk of Infective endocarditis (IE) was in their protocol for the prevention of IE published in 1977. This practice was included by the AHA and adopted by other expert committees such as the British Society for Antimicrobial Chemotherapy (BSAC) in subsequent prophylactic regimens. In 1992, the BSAC specified the presentation and concentration of chlorhexidine (CHX) that should be used before starting the dental procedure: 1% gel at the gingival margin or 0.2% mouthwash for five minutes. In 1997, the AHA recognised the need to use antiseptic mouthwashes (CHX or povidone iodine) prior to dental manipulations, although they recommended against the use of gingival irrigators and against the continuous use of antiseptics in order to avoid the selection of resistant micro-organisms In 2006, the BSAC recommended a single mouthwash with 0.2% CHX gluconate (10 ml for 1 minute) before performing dental procedures associated with bacteraemia in patients at risk of IE. In contrast, in 2007, the AHA recommended against the use of any antiseptic prophylaxis protocol. In 2008, the National Institute for Health and Clinical Excellence of the United Kingdom recently performed a systematic review of the antimicrobial prophylaxis protocols for IE and reported that: "Oral chlorhexidine used as an oral rinse does not significantly reduce the level of bacteraemia following dental procedures". This conclusion was reached after analysis of numerous studies on the efficacy of prophylaxis with CHX for the prevention of post-dental manipulation bacteraemia. However, those studies presented significant methodological differences not only in the dental procedures performed, but also in the concentration of CHX applied and the method of application of the antiseptic solution (mouthwash and/or irrigation), making comparison of the results of the different series difficult. There are few studies that have analysed the efficacy of the mouthwash of 0.2% CHX (the concentration recommended by the BSAC) in the prevention of post-extraction bacteraemia. Only one study analysed the combination of local irrigation and mouthwash with chlorhexidine before dental extraction, but with a really lower concentration of CHX, only 0.02%. The objective of this study is to investigate the prevalence, duration and aetiology of bacteraemia secondary to a single tooth extraction after prophylaxis with different CHX protocols.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
208

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Dec 2010

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2010

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

May 16, 2014

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 29, 2014

Completed
Last Updated

May 29, 2014

Status Verified

May 1, 2014

Enrollment Period

1.4 years

First QC Date

May 16, 2014

Last Update Submit

May 25, 2014

Conditions

Keywords

prevention and controlchlorhexidinetherapeutic irrigationmouthwashesculture

Outcome Measures

Primary Outcomes (1)

  • Changes in the prevalence of bacteraemia

    Presence of bacteria and how long it lasts in the blood stream.

    before and 30 seconds after the antiseptic aplication and 30 seconds and 15 minutes after dental extraction.

Study Arms (4)

Control

OTHER

* Blood extraction using the intravenous access 18-22 gauge "angiocath" catheter (Becton Dickinson, Sparks, MD, USA) (at baseline, 30 seconds and 15 minutes after tooth extraction). * No prophylactic Chlorhexidine regimen. * Local anesthesia with lidocaine plus adrenaline (1:100,000). * Tooth extraction.

Procedure: Blood extractionDrug: Lidocaine plus adrenalineProcedure: Tooth extraction

CHX-Mouthwash

ACTIVE COMPARATOR

* Blood extraction using the intravenous access 18-22 gauge "angiocath" catheter (Becton Dickinson, Sparks, MD, USA)(at baseline, 30 seconds and 15 minutes after tooth extraction). * Mouthwash with 0.2% Chlorhexidine (10 ml for 1 minute) (Oraldine Perio®, Johnson and Johnson, Barcelona, Spain). * Local anesthesia with lidocaine plus adrenaline (1:100,000). * Tooth extraction.

Drug: 0.2% ChlorhexidineProcedure: Blood extractionDrug: Lidocaine plus adrenalineProcedure: Tooth extraction

CHX-MW/SUB_IR

ACTIVE COMPARATOR

* Blood extraction using the intravenous access 18-22 gauge "angiocath" catheter (Becton Dickinson, Sparks, MD, USA) (at baseline, 30 seconds and 15 minutes after tooth extraction). * Mouthwash with 0.2% Chlorhexidine (10 ml for 1 minute) (Oraldine Perio®) and subgingival irrigation with 1% Chlorhexidine on the tooth to be extracted; the irrigation will be done with the Heraeus Citojet Intraligamental Syringe (Kulzer Heraeus S.A., Madrid, Spain) at six points on each tooth (3 points on the vestibular surface and 3 on the palatine surface). * Local anesthesia with lidocaine plus adrenaline (1:100,000). * Tooth extraction.

Drug: 0.2% ChlorhexidineDrug: 1% ChlorhexidineProcedure: Blood extractionDrug: Lidocaine plus adrenalineProcedure: Tooth extraction

CHX-MW/SUPRA_IR

ACTIVE COMPARATOR

* Blood extraction using the intravenous access 18-22 gauge "angiocath" catheter (Becton Dickinson, Sparks, MD, USA)(at baseline, 30 seconds and 15 minutes after tooth extraction). * Mouthwash with 0.2% Chlorhexidine (10 ml for 1 minute) (Oraldine Perio®) and then supragingival irrigation with 1% Chlorhexidine on the tooth to be extracted; the irrigation will be done continuously around the tooth to be extracted by a conventional syringe. * Local anesthesia with lidocaine plus adrenaline (1:100,000). * Tooth extraction.

Drug: 0.2% ChlorhexidineDrug: 1% ChlorhexidineProcedure: Blood extractionDrug: Lidocaine plus adrenalineProcedure: Tooth extraction

Interventions

mouthwash with 10 ml for 1 minute

Also known as: OraldinePerio, Chlorhexidine 0.2%
CHX-MW/SUB_IRCHX-MW/SUPRA_IRCHX-Mouthwash

subgingival irrigation

Also known as: Normosept 1g/100ml sloution, Chlorhexidine 1%
CHX-MW/SUB_IR

Blood extraction using an intravenous access at baseline, 30 seconds after antiseptic aplication, 30 seconds and 15 minutes after tooth extraction.

CHX-MW/SUB_IRCHX-MW/SUPRA_IRCHX-MouthwashControl

local anaesthesia using lidocaine plus adrenaline (1:100,000) no more than 2 cartridges.

Also known as: anaesthesia
CHX-MW/SUB_IRCHX-MW/SUPRA_IRCHX-MouthwashControl

dental extraction

CHX-MW/SUB_IRCHX-MW/SUPRA_IRCHX-MouthwashControl

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • with need for dental extraction

You may not qualify if:

  • patients under 18 years of age
  • antibiotic treatment in the previous three months
  • routine use of oral antiseptics
  • any type of congenital or acquired immunodeficiency or other disease that could favour the onset of infection or haemorrhagic complications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Stomatology and Maxillofacial Surgery of the Santo Antonio General Hospital

Porto, Porto District, 4099-001 PORTO, Portugal

Location

Department of Stomatology University of Santiago de Compostela

Santiago de Compostela, Galicia/A Coruña, 15782, Spain

Location

Related Publications (5)

  • Tomas I, Alvarez M, Limeres J, Tomas M, Medina J, Otero JL, Diz P. Effect of a chlorhexidine mouthwash on the risk of postextraction bacteremia. Infect Control Hosp Epidemiol. 2007 May;28(5):577-82. doi: 10.1086/516663. Epub 2007 Apr 5.

    PMID: 17464918BACKGROUND
  • Tomas I, Alvarez M, Limeres J, Potel C, Medina J, Diz P. Prevalence, duration and aetiology of bacteraemia following dental extractions. Oral Dis. 2007 Jan;13(1):56-62. doi: 10.1111/j.1601-0825.2006.01247.x.

    PMID: 17241431BACKGROUND
  • Benitez-Paez A, Alvarez M, Belda-Ferre P, Rubido S, Mira A, Tomas I. Detection of transient bacteraemia following dental extractions by 16S rDNA pyrosequencing: a pilot study. PLoS One. 2013;8(3):e57782. doi: 10.1371/journal.pone.0057782. Epub 2013 Mar 4.

    PMID: 23469240BACKGROUND
  • Pineiro A, Tomas I, Blanco J, Alvarez M, Seoane J, Diz P. Bacteraemia following dental implants' placement. Clin Oral Implants Res. 2010 Sep;21(9):913-8. doi: 10.1111/j.1600-0501.2010.01928.x.

    PMID: 20701619BACKGROUND
  • Barbosa M, Prada-Lopez I, Alvarez M, Amaral B, de los Angeles CD, Tomas I. Post-tooth extraction bacteraemia: a randomized clinical trial on the efficacy of chlorhexidine prophylaxis. PLoS One. 2015 May 8;10(5):e0124249. doi: 10.1371/journal.pone.0124249. eCollection 2015.

MeSH Terms

Conditions

Bacteremia

Interventions

ChlorhexidineSolutionsLidocaineEpinephrineAnesthesiaTooth Extraction

Condition Hierarchy (Ancestors)

Bacterial InfectionsBacterial Infections and MycosesInfectionsSepsisSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

BiguanidesGuanidinesAmidinesOrganic ChemicalsPharmaceutical PreparationsAcetanilidesAnilidesAmidesAniline CompoundsAminesEthanolaminesAmino AlcoholsAlcoholsBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsAnesthesia and AnalgesiaOral Surgical ProceduresSurgical Procedures, OperativeDentistry

Study Officials

  • Inmaculada Tomas

    Senior lecturer at University of Santiago de Compostela

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior lecturer

Study Record Dates

First Submitted

May 16, 2014

First Posted

May 29, 2014

Study Start

December 1, 2010

Primary Completion

May 1, 2012

Study Completion

June 1, 2012

Last Updated

May 29, 2014

Record last verified: 2014-05

Locations